Sign in
4

Changes in Ownership

Jazz Pharmaceuticals plc Filed Acc 0001765581-22-000002

Chairman & CEO sold 5,791 shares at an average $127.85 ($740,387)

  • Chairman & CEO acquired 9,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

COZADD BRUCE C · Chairman & CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-03 Exercise or conversion : show line 1 in the form +9,700 $46.83 $454,251 328,251 D
2022-01-03 Sale : show line 2 in the form −1,819 $126.72 $230,504 326,432 D
2022-01-03 Sale : show line 3 in the form −1,181 $127.58 $150,672 325,251 D
2022-01-03 Sale : show line 4 in the form −2,651 $128.67 $341,104 322,600 D
2022-01-03 Sale : show line 5 in the form −140 $129.34 $18,108 322,460 D
Open-market sales · 5,791 sh · avg $127.85 · $740,387

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −9,700 67,832 D
Loading xslF345X03/edgardoc.xml…